WASHINGTON — The White House at long last published a plan to stem drug shortages, and it involves basing Government-run Medicare pay to hospitals on whether hospitals adopt business practices that avoid shortages.
The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages, including cancer drugs. As of late last summer, lawmakers working on drug shortage legislation hadn’t spoken to the task force and didn’t know who was in charge of it.
There are many proposals in Congress for fixing the problem, but they don’t form a cohesive whole. The various approaches include improving drug manufacturing, boosting domestic manufacturing, giving hospitals the incentive to buy from generic drugmakers that maintain resilient supply chains, and helping generic drugmakers charge higher prices.
Click this link for the original source of this article.
Author: John Wilkerson
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.